PT Merck Tbk (MERK.JK)
IDR 3580.0
(0.85%)
IDR 3580.0
(0.85%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 178.24 Billion IDR | -0.89% |
| 2022 | 179.83 Billion IDR | 36.59% |
| 2021 | 131.66 Billion IDR | 83.11% |
| 2020 | 71.9 Billion IDR | -8.12% |
| 2019 | 78.25 Billion IDR | -93.27% |
| 2018 | 1163.32 Billion IDR | 704.08% |
| 2017 | 144.67 Billion IDR | -5.96% |
| 2016 | 153.84 Billion IDR | 7.93% |
| 2015 | 142.54 Billion IDR | -21.45% |
| 2014 | 181.47 Billion IDR | 3.44% |
| 2013 | 175.44 Billion IDR | 62.74% |
| 2012 | 107.8 Billion IDR | -53.36% |
| 2011 | 231.15 Billion IDR | 94.59% |
| 2010 | 118.79 Billion IDR | -19.02% |
| 2009 | 146.7 Billion IDR | 48.75% |
| 2008 | 98.62 Billion IDR | 10.21% |
| 2007 | 89.48 Billion IDR | 3.41% |
| 2006 | 86.53 Billion IDR | 49.98% |
| 2005 | 57.7 Billion IDR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q3 | 29.21 Billion IDR | 24.08% |
| 2024 Q2 | 23.54 Billion IDR | -0.47% |
| 2024 Q1 | 23.65 Billion IDR | -50.56% |
| 2023 FY | 178.24 Billion IDR | -0.89% |
| 2023 Q4 | 47.84 Billion IDR | 22.61% |
| 2023 Q3 | 39.02 Billion IDR | -13.38% |
| 2023 Q2 | 45.05 Billion IDR | -2.71% |
| 2023 Q1 | 46.3 Billion IDR | 53.9% |
| 2022 Q3 | 26.34 Billion IDR | -56.66% |
| 2022 Q2 | 60.78 Billion IDR | -2.91% |
| 2022 Q1 | 62.61 Billion IDR | 351.38% |
| 2022 FY | 179.83 Billion IDR | 36.59% |
| 2022 Q4 | 30.09 Billion IDR | 14.21% |
| 2021 FY | 131.66 Billion IDR | 83.11% |
| 2021 Q1 | 53.31 Billion IDR | 216.7% |
| 2021 Q2 | 28.22 Billion IDR | -47.06% |
| 2021 Q3 | 36.24 Billion IDR | 28.42% |
| 2021 Q4 | 13.87 Billion IDR | -61.73% |
| 2020 FY | 71.9 Billion IDR | -8.12% |
| 2020 Q2 | -2.87 Billion IDR | -108.21% |
| 2020 Q4 | 16.83 Billion IDR | -26.64% |
| 2020 Q1 | 34.99 Billion IDR | -42.82% |
| 2020 Q3 | 22.94 Billion IDR | 899.13% |
| 2019 FY | 78.25 Billion IDR | -93.27% |
| 2019 Q1 | 11.55 Billion IDR | -98.87% |
| 2019 Q2 | -5.43 Billion IDR | -147.03% |
| 2019 Q3 | 10.94 Billion IDR | 301.44% |
| 2019 Q4 | 61.18 Billion IDR | 458.9% |
| 2018 Q3 | 48.06 Billion IDR | 26.17% |
| 2018 Q2 | 38.09 Billion IDR | -27.03% |
| 2018 FY | 1163.32 Billion IDR | 704.08% |
| 2018 Q1 | 52.21 Billion IDR | 930.5% |
| 2018 Q4 | 1024.95 Billion IDR | 2032.47% |
| 2017 Q2 | 34.86 Billion IDR | -47.0% |
| 2017 FY | 144.67 Billion IDR | -5.96% |
| 2017 Q4 | -6.28 Billion IDR | -112.49% |
| 2017 Q3 | 50.31 Billion IDR | 44.33% |
| 2017 Q1 | 65.78 Billion IDR | 131.67% |
| 2016 FY | 153.84 Billion IDR | 7.93% |
| 2016 Q1 | 60.3 Billion IDR | 186.6% |
| 2016 Q2 | 36.69 Billion IDR | -39.15% |
| 2016 Q3 | 28.44 Billion IDR | -22.5% |
| 2016 Q4 | 28.39 Billion IDR | -0.17% |
| 2015 Q1 | 50.24 Billion IDR | 27.62% |
| 2015 Q2 | 39.69 Billion IDR | -20.99% |
| 2015 Q3 | 31.56 Billion IDR | -20.49% |
| 2015 Q4 | 21.04 Billion IDR | -33.33% |
| 2015 FY | 142.54 Billion IDR | -21.45% |
| 2014 FY | 181.47 Billion IDR | 3.44% |
| 2014 Q1 | 61.81 Billion IDR | 198.98% |
| 2014 Q2 | 39.93 Billion IDR | -35.4% |
| 2014 Q4 | 39.36 Billion IDR | -2.44% |
| 2014 Q3 | 40.35 Billion IDR | 1.05% |
| 2013 FY | 175.44 Billion IDR | 62.74% |
| 2013 Q4 | 20.67 Billion IDR | -42.25% |
| 2013 Q3 | 35.8 Billion IDR | -3.56% |
| 2013 Q2 | 37.12 Billion IDR | -54.64% |
| 2013 Q1 | 81.84 Billion IDR | 5827.28% |
| 2012 Q2 | 41.45 Billion IDR | 6.52% |
| 2012 Q4 | 1.38 Billion IDR | -94.7% |
| 2012 FY | 107.8 Billion IDR | -53.36% |
| 2012 Q1 | 38.91 Billion IDR | -62.9% |
| 2012 Q3 | 26.05 Billion IDR | -37.13% |
| 2011 FY | 231.15 Billion IDR | 94.59% |
| 2011 Q3 | 35.21 Billion IDR | -22.18% |
| 2011 Q2 | 45.25 Billion IDR | -1.19% |
| 2011 Q1 | 45.79 Billion IDR | 68.32% |
| 2011 Q4 | 104.89 Billion IDR | 197.84% |
| 2010 Q4 | 27.2 Billion IDR | 0.0% |
| 2010 FY | 118.79 Billion IDR | -19.02% |
| 2010 Q1 | 39.87 Billion IDR | 23.5% |
| 2009 FY | 146.7 Billion IDR | 48.75% |
| 2009 Q4 | 32.28 Billion IDR | 0.0% |
| 2009 Q1 | 40.27 Billion IDR | 0.0% |
| 2008 FY | 98.62 Billion IDR | 10.21% |
| 2007 FY | 89.48 Billion IDR | 3.41% |
| 2006 FY | 86.53 Billion IDR | 49.98% |
| 2005 FY | 57.7 Billion IDR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| PT Darya-Varia Laboratoria Tbk | 146.33 Billion IDR | -21.802% |
| PT Phapros, Tbk | 5.95 Billion IDR | -2890.941% |
| PT Pyridam Farma Tbk | -85.22 Billion IDR | 309.15% |
| PT Industri Jamu dan Farmasi Sido Muncul Tbk | 950.64 Billion IDR | 81.251% |
| PT Tempo Scan Pacific Tbk | 1177.43 Billion IDR | 84.862% |